Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
Open Access
- 12 February 2013
- journal article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 27
Abstract
Adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn in patients with ulcerative colitis (UC) has been applied as a non-pharmacological treatment strategy, but the efficacy has been encouraging as well as discouraging, depending on patients’ demography at entry. In this study, we looked for predictive factors for clinical response to GMA in patients with UC.Keywords
This publication has 36 references indexed in Scilit:
- The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscessesJournal of Crohn's and Colitis, 2012
- Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.Journal of Crohn's and Colitis, 2012
- Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytesJournal of Gastroenterology, 2011
- Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: A prospective cohort studyInflammatory Bowel Diseases, 2010
- Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: Results, practical issues, safety, and future perspectivesInflammatory Bowel Diseases, 2009
- Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II TrialAmerican Journal of Gastroenterology, 2005
- Selective Granulocyte and Monocyte Adsorptive Apheresis as a First-Line Treatment for Steroid Naïve Patients with Active Ulcerative Colitis: A Prospective Uncontrolled StudyDigestive Diseases and Sciences, 2004
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitisAmerican Journal of Gastroenterology, 2001
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989